September 7, 2006

Takeda Pharmaceutical Company Limited

Notice of Execution of Acquisition of the Company's Own Shares

Osaka, Japan, September 7, 2006 --- Takeda Pharmaceutical Company Limited ("Takeda") announced today that it completed acquisition of its own shares in the market, which was resolved by its Board of Directors on July 31, 2006.

1. Type of shares acquired	:	Shares of common stock
2. Period of acquisition	:	From August 1, 2006 to September 6, 2006
3. Total number of shared acquired	:	5,614,000 shares
4. Total value of acquisition	:	Yen 43,083,794,000
5. Method of acquisition	:	Purchased on the Tokyo Stock Exchange

(Reference)

Resolution of the Board of Directors on July 31, 2006

1. Type of shares to be acquired	:	Shares of common stock
2. Number of shares to be acquired	:	14 million shares (maximum)
		(equivalent to 1.57% of a total of issued shares)
3. Total value of shares to be acquired	:	Yen 100 billion (maximum)
4. Schedule of acquisition	:	From August 1, 2006 to September 6, 2006

# # #